Boulenger J P, Fournier M, Rosales D, Lavallée Y J
Centre Universitaire de Santé de l'Estrie, Department of Psychiatry, Sherbrooke, Quebec, Canada.
J Clin Psychiatry. 1997;58 Suppl 8:27-34.
The 10th International Classification of Disease (ICD-10) introduced the concept of mixed anxiety-depression to define patients presenting both anxiety and depressive symptoms of limited number and/or intensity, not sufficiently severe to fulfill criteria for a specific diagnosis of depressive or anxiety disorder. Epidemiologic surveys have shown that these patients may display significant levels of functional impairment, have unexplained somatic symptoms and a high use of nonpsychiatric medical care, have long-lasting symptoms, and are at risk for more severe psychiatric disorders. A DSM-IV field trial concluded that patients with affective-symptoms not meeting thresholds for DSM-III-R disorders were at least as common as patients with anxiety or mood disorders, and that their symptoms were associated with significant distress or impairment. Although some of these patients present residual symptoms from previous psychiatric episodes and may request treatment specific to these conditions, it is not known if those without a psychiatric history could benefit from pharmacologic or psychological treatments usually used in mild outpatient cases.
第十版国际疾病分类(ICD - 10)引入了混合性焦虑抑郁的概念,用于定义那些同时出现数量有限和/或强度较轻的焦虑和抑郁症状,但严重程度不足以满足特定抑郁或焦虑障碍诊断标准的患者。流行病学调查表明,这些患者可能表现出显著的功能损害,有无法解释的躯体症状且大量使用非精神科医疗服务,症状持续时间长,并且有患更严重精神障碍的风险。一项《精神疾病诊断与统计手册》第四版(DSM - IV)现场试验得出结论,情感症状未达到DSM - III - R障碍阈值的患者至少与焦虑或情绪障碍患者一样常见,并且他们的症状与明显的痛苦或损害相关。虽然其中一些患者存在先前精神疾病发作的残留症状,可能需要针对这些情况的治疗,但尚不清楚那些没有精神病史的患者是否能从通常用于轻度门诊病例的药物或心理治疗中获益。